1lm8: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1lm8" size="450" color="white" frame="true" align="right" spinBox="true" caption="1lm8, resolution 1.85Å" /> '''Structure of a HIF-...
 
OCA (talk | contribs)
No edit summary
 
(17 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1lm8.gif|left|200px]]<br />
<applet load="1lm8" size="450" color="white" frame="true" align="right" spinBox="true"
caption="1lm8, resolution 1.85&Aring;" />
'''Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex'''<br />


==Overview==
==Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex==
The ubiquitination of the hypoxia-inducible factor (HIF) by the von, Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular, response to changes in oxygen availability. pVHL binds to HIF only when a, conserved proline in HIF is hydroxylated, a modification that is, oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1alpha, peptide-pVHL-ElonginB-ElonginC complex shows that HIF-1alpha binds to pVHL, in an extended beta strand-like conformation. The hydroxyproline inserts, into a gap in the pVHL hydrophobic core, at a site that is a hotspot for, tumorigenic mutations, with its 4-hydroxyl group recognized by buried, serine and histidine residues. Although the beta sheet-like interactions, contribute to the stability of the complex, the hydroxyproline contacts, are central to the strict specificity characteristic of signaling.
<StructureSection load='1lm8' size='340' side='right'caption='[[1lm8]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1lm8]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1LM8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1LM8 FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1lm8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1lm8 OCA], [https://pdbe.org/1lm8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1lm8 RCSB], [https://www.ebi.ac.uk/pdbsum/1lm8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1lm8 ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/ELOB_HUMAN ELOB_HUMAN] SIII, also known as elongin, is a general transcription elongation factor that increases the RNA polymerase II transcription elongation past template-encoded arresting sites. Subunit A is transcriptionally active and its transcription activity is strongly enhanced by binding to the dimeric complex of the SIII regulatory subunits B and C (elongin BC complex).<ref>PMID:7638163</ref> <ref>PMID:15590694</ref>  The elongin BC complex seems to be involved as an adapter protein in the proteasomal degradation of target proteins via different E3 ubiquitin ligase complexes, including the von Hippel-Lindau ubiquitination complex CBC(VHL). By binding to BC-box motifs it seems to link target recruitment subunits, like VHL and members of the SOCS box family, to Cullin/RBX1 modules that activate E2 ubiquitination enzymes.<ref>PMID:7638163</ref> <ref>PMID:15590694</ref>
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/lm/1lm8_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1lm8 ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1alpha peptide-pVHL-ElonginB-ElonginC complex shows that HIF-1alpha binds to pVHL in an extended beta strand-like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the beta sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.


==Disease==
Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.,Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP Science. 2002 Jun 7;296(5574):1886-9. Epub 2002 May 9. PMID:12004076<ref>PMID:12004076</ref>
Known diseases associated with this structure: Hemangioblastoma, cerebellar, somatic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=608537 608537]], Pheochromocytoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=608537 608537]], Polycythemia, benign familial OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=608537 608537]], Renal cell carcinoma, somatic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=608537 608537]], von Hippel-Lindau syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=608537 608537]]


==About this Structure==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
1LM8 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1LM8 OCA].
</div>
<div class="pdbe-citations 1lm8" style="background-color:#fffaf0;"></div>


==Reference==
==See Also==
Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling., Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP, Science. 2002 Jun 7;296(5574):1886-9. Epub 2002 May 9. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=12004076 12004076]
*[[Elongation factor 3D structures|Elongation factor 3D structures]]
*[[Factor inhibiting HIF|Factor inhibiting HIF]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Large Structures]]
[[Category: Gertler, F.]]
[[Category: Gertler F]]
[[Category: Ivan, M.]]
[[Category: Ivan M]]
[[Category: JR., W.G.Kaelin.]]
[[Category: Kaelin JR WG]]
[[Category: Min, J-H]]
[[Category: Min J-H]]
[[Category: Pavletich, N.P.]]
[[Category: Pavletich NP]]
[[Category: Yang, H.]]
[[Category: Yang H]]
[[Category: oxygen sensing]]
[[Category: regulation]]
[[Category: tumor suppressor]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:02:30 2007''